Optic Nerve Neoplasms - 25 Studies Found
Terminated |
: Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1. : Neurofibromatosis Type 1 : 2014-02-26 |
Recruiting |
: A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas :
|
Active, not recruiting |
: PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1) :
|
Active, not recruiting |
: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma :
|
Terminated |
: Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas :
: Drug: Sorafenib (Nexavar) Sorafenib (in tablet form) will |
Withdrawn |
: Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma : Optic Nerve Glioma : 2010-12-13 :
|
Recruiting |
: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma :
|
Terminated |
: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia :
|
Completed |
: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors :
|
Completed |
: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma :
|